National Bank of Canada
ZOM

National Bank of Canada’s Zomedica Corp. ZOM Stock Holding History

National Bank of Canada’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,500
Closed -$180 – 3245
2024
Q4 		$180 Buy
+1,500
New +$189 ﹤0.01% 2768

Other funds holding ZOM

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
PRTG
Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
GJIA
Glass Jacobson Investment Advisors Owings Mills, Maryland $321M AUM 20.69% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $10.3B AUM 25.54% 1-Year Est. Return

National Bank of Canada's ZOM Position: Q1 2025 in Review

National Bank of Canada sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 1,500 shares — an estimated $180 sold.

National Bank of Canada first reported a position in ZOM in Q4 2024 and held it in 1 quarter. The position peaked at $180 in Q4 2024. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • National Bank of Canada reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • National Bank of Canada sold 1,500 Zomedica Corp. shares in Q1 2025, an estimated $180.
  • National Bank of Canada first reported a position in Zomedica Corp. in Q4 2024 and held it in 1 quarter.
  • National Bank of Canada's Zomedica Corp. position peaked at $180 in Q4 2024.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on National Bank of Canada's 13F filing for Q1 2025, filed 12 May 2025.